We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Alnylam Pharmaceuticals Inc | NASDAQ:ALNY | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.8401 | 0.56% | 150.8001 | 150.80 | 155.46 | 177 | 13:02:26 |
From May 2019 to May 2024
NEW YORK, July 17, 2015 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential wrongdoing at Alnylam Pharmaceuticals, Inc. ("Alnylam" or the "Company") (NASDAQ: ALNY).
The investigation focuses on whether the Company and its officers breached their fiduciary duties with respect to the Alnylam's corporate governance controls.
Request more information now by clicking here: www.faruqilaw.com/ALNY. There is no cost or obligation to you.
Take Action
If you currently own Alnylam stock and have continuously owned Alnylam stock and would like to discuss your legal rights, please visit www.faruqilaw.com/ALNY. You can also contact us by calling Nadeem Faruqi toll free at (212) 983-9330 or by sending an e-mail to nfaruqi@faruqilaw. Faruqi & Faruqi, LLP also encourages anyone with information regarding Alnylam's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Nadeem Faruqi
nfaruqi@faruqilaw.com
Telephone: (212) 983-9330
Logo - http://photos.prnewswire.com/prnh/20120119/MM38856LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/faruqi--faruqi-llp-is-investigating-alnylam-pharmaceuticals-inc-alny-on-behalf-of-its-shareholders-300114950.html
SOURCE Faruqi & Faruqi, LLP
Copyright 2015 PR Newswire
1 Year Alnylam Pharmaceuticals Chart |
1 Month Alnylam Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
